Axa’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-185,100
| Closed | -$3.77M | – | 272 |
|
|
2025
Q2 | $3.77M | Buy |
185,100
+297
| +0.2% | +$5.78K | 0.01% | 623 |
|
|
2025
Q1 | $3.35M | Sell |
184,803
-237
| -0.1% | -$5.29K | 0.01% | 629 |
|
|
2024
Q4 | $4.68M | Sell |
185,040
-294
| -0.2% | -$7.99K | 0.01% | 556 |
|
|
2024
Q3 | $6.3M | Buy |
185,334
+43,044
| +30% | +$1.64M | 0.02% | 484 |
|
|
2024
Q2 | $5.27M | Buy |
142,290
+81
| +0.1% | +$3.06K | 0.02% | 524 |
|
|
2024
Q1 | $5.97M | Buy |
142,209
+39
| +0% | +$1.6K | 0.02% | 515 |
|
|
2023
Q4 | $5.64M | Sell |
142,170
-3,439
| -2% | -$101K | 0.02% | 526 |
|
|
2023
Q3 | $4.01M | Buy |
145,609
+31,479
| +28% | +$987K | 0.01% | 573 |
|
|
2023
Q2 | $3.87M | Buy |
114,130
+1,570
| +1% | +$52.9K | 0.01% | 608 |
|
|
2023
Q1 | $4.05M | Sell |
112,560
-259
| -0.2% | -$11.2K | 0.01% | 618 |
|
|
2022
Q4 | $5.03M | Sell |
112,819
-46,400
| -29% | -$1.66M | 0.02% | 596 |
|
|
2022
Q3 | $4.48M | Buy |
159,219
+31,403
| +25% | +$963K | 0.02% | 597 |
|
|
2022
Q2 | $3.45M | Sell |
127,816
-27,107
| -17% | -$787K | 0.01% | 663 |
|
|
2022
Q1 | $5.28M | Sell |
154,923
-3,999
| -3% | -$128K | 0.02% | 631 |
|
|
2021
Q4 | $6.14M | Sell |
158,922
-4,061
| -2% | -$177K | 0.02% | 614 |
|
|
2021
Q3 | $8.8M | Sell |
162,983
-65,968
| -29% | -$3.1M | 0.02% | 534 |
|
|
2021
Q2 | $7.66M | Sell |
228,951
-68,832
| -23% | -$1.89M | 0.02% | 589 |
|
|
2021
Q1 | $6.13M | Buy |
297,783
+287,283
| +2,736% | +$6.6M | 0.02% | 652 |
|
|
2020
Q4 | $184K | Buy |
+10,500
| New | +$189K | ﹤0.01% | 1180 |
|
|
2018
Q2 | – | Sell |
-18,607
| Closed | -$650K | – | 1354 |
|
|
2018
Q1 | $650K | Hold |
18,607
| – | – | ﹤0.01% | 1107 |
|
|
2017
Q4 | $793K | Sell |
18,607
-13,983
| -43% | -$599K | ﹤0.01% | 1065 |
|
|
2017
Q3 | $1.4M | Buy |
32,590
+7
| +0% | +$262 | 0.01% | 893 |
|
|
2017
Q2 | $1.21M | Hold |
32,583
| – | – | 0.01% | 892 |
|
|
2017
Q1 | $1.76M | Buy |
32,583
+13,860
| +74% | +$722K | 0.01% | 808 |
|
|
2016
Q4 | $994K | Buy |
18,723
+490
| +3% | +$27.9K | ﹤0.01% | 908 |
|
|
2016
Q3 | $1.1M | Buy |
+18,233
| New | +$1.14M | ﹤0.01% | 881 |
|
|
2015
Q3 | – | Sell |
-25,512
| Closed | -$9.65M | – | 1456 |
|
|
2015
Q2 | $9.65M | Hold |
25,512
| – | – | 0.04% | 432 |
|
|
2015
Q1 | $10.7M | Buy |
25,512
+1,801
| +8% | +$644K | 0.04% | 390 |
|
|
2014
Q4 | $6.49M | Buy |
23,711
+1,228
| +5% | +$305K | 0.03% | 487 |
|
|
2014
Q3 | $4.37M | Buy |
+22,483
| New | +$4.9M | 0.02% | 573 |
|
Other funds holding CLDX
KCM
BG
CC